Esperion Therapeutics Inc (ESPR) Q2 2020 Earnings Call Transcript
With me on today's call are Tim Mayleben, President and Chief Executive Officer; Mark Glickman, Chief Commercial Officer; and Rick Bartram, Chief Financial Officer. Actual results could differ materially from those stated or implied by our forward-looking statements due to the risks and uncertainties associated with the business.